|
|
 |
 |
 After 60 years of development, Wuhan Grand Pharmaceutical Group Co., Ltd has grown into a medical joint venture with modernized scale with a registered capital of 85 million yuan, a site area of 300 mu, and a building area of 96,000 square meters. The main products of the company are pharmaceutical preparations, pharmaceutical raw materials and intermediate products. With an annual sales income of 400 million yuan, annual foreign exchange 15 million yuan, and an annual production capacity of 200 million liquid preparations, more than 4 billion solid preparations, and over 4,000 tons of pharmaceutical raw materials, it is a designated enterprise of the emergency medicines for the national war reserves and narcotics. Wuhan Grand Pharmaceutical Group Co., Ltd was founded in 1939 in the Revolutionary Base of Taihang Mountain. It is the former Eighth Route Army Sanitary Materials Plant, which made great contributions to the War of Resistance Against Japan and the War of Liberation. Chairman Mao once wrote an inscription for it: "Develop medicines for therapy and be brave in the embargo is one of the requirements to conquer the enemy."
Following the core values of “new products, new markets and new demand" and sticking to the development direction of “dual structure” for raw materials and preparations, the company focuses on product development in such fields as cardiovascular, ophthalmology, liver-protective medicines, antibiotics and unique raw materials; with a professional scientific research team, the scientific research work has moved towards marketization and industrialization with an annual investment of more than 10 million yuan on the development of new products, and 3 types of the National Category Ⅱ New Drug and 9 types of the National Category Ⅳ New Drug have been successively developed on a independent basis, and a number of new drugs are in registration. The company has now formed the antibacterial category with Enoxacin Gluconate Series at the core, the cardiovascular category with Tirofiban Hydrochloride and Sodium Chloride Injection at the core, the ophthalmic category with Ganciclovir Sodium for Injection and Pirenoxine Sodium eye drops at the core, and new and unique products to cure liver disease like Nuoning Series. Our products are sold to dozens of countries and regions like Asia, Europe and the United States and it is recognized as the key “Hi-Tech Enterprise” of the “Torch Plan” of the Ministry of Science and Technology.
Nspired by the vision of “Build a century-old pharmaceutical enterprise to repay the society”, the company has forged its unique development track with morality and mission; while developing itself, the company never forgets the social benefits and public responsibility of the pharmaceutical enterprise. Over the past 60 years, with the mission of healing the wounded and rescuing the dying, and making contributions to the health of people, the company has undertaken its social morality in strengthening the national defense by producing a number of "life-saving drugs" and "much-needed drugs".
The advancing company is developing at “a speed above the average speed in the industry” and strives to be a leading enterprise in the chemical pharmaceutical industry in Hubei Province within 3 years.
|
|
|
|
|
